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Abstract In vertebrates, cytosine methylation is an epigenetic
DNA modification that participates in genome stability and gene
repression. Methylation patterns are either maintained through-
out cell division, or modified by global or local de novo
methylation and demethylation. Site-specific demethylation is a
rather elusive process that occurs mainly in parallel to gene
activation during development. In light of our studies of the
glucocorticoid-dependent DNA demethylation of the tyrosine
aminotransferase gene, we discuss the potential biochemical
mechanisms allowing DNA demethylation and its targeting to
specific sequences by transcription factors as well as possible
links to DNA replication and chromatin remodelling. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
In most vertebrates, 60^90% of the cytosines at CpG dinu-
cleotides are methylated [1]. The presence of the methyl moi-
ety on the base contributes generally to transcriptional repres-
sion by preventing regulators from binding to their target, or
favouring the formation of inactive chromatin [2,3]. The
methylation pattern is correlated with the activity of the
gene and constitutes a stable epigenetic mark that is trans-
mitted through DNA replication and cellular division. Meth-
ylation plays a functional role in genome organisation and
stability [4,5], and in some aspects of gene expression, namely
the silencing of mobile elements [6], genomic imprinting [7]
and X chromosome inactivation [8]. Dysfunction of methyla-
tion control could be involved in cancer [9]. In mammals,
modi¢cations of methylation patterns occur during develop-
ment but their importance for gene regulation is still discussed
[10,11]. The methylation pattern of the mammalian embryo
genome is established after fertilisation through several steps
involving genome-wide demethylation and de novo methyla-
tion, followed by selective demethylation of regulatory ele-
ments occurring in parallel with their activation [12,13]. In
other vertebrates, methylation could also participate in the
control of gene expression during development even though
it is not clear whether genome-wide modi¢cations of methyl-
ation occur in all vertebrates [14,15]. Whereas the methylation
process has become clearer since the identi¢cation of de novo
and maintenance DNA methyltransferases (DNMT) [16], de-
methylation mechanisms have not yet been elucidated.
1.1. Global versus local demethylation
Two kinds of demethylation events can be distinguished:
global and site-speci¢c demethylation. In mammals, a large
portion of the genome undergoes demethylation during game-
togenesis, early development of the embryo and in some dif-
ferentiating cells [13,17]. In many vertebrates, site-speci¢c de-
methylation a¡ects tissue-speci¢c genes in the tissue and
developmental stage where they are expressed and may be
involved in the absence of methylation of CpG islands [18].
Global and local demethylation are clearly distinct in their
regulation and may be carried out by di¡erent mechanisms.
Genome-wide demethylation could result from a global pro-
cess acting on the cellular pool of enzymes involved in con-
trolling DNA methylation, following either inactivation of
DNMTs or activation of demethylating enzymes [19]. In con-
trast, local demethylation must be targeted (directly or not) to
speci¢c sequences by regulatory factors that could either re-
cruit the activities involved in genome-wide demethylation, or
use speci¢c mechanisms better adapted to a precise action.
Attempts to elucidate the demethylation event in vitro have
generated diverging results, which may be due, in part, to
di¡erent activities being analysed that are involved in di¡erent
demethylation events. Clari¢cation of the issue could be ob-
tained through analysis of the biochemistry of the demethyla-
tion reaction actually taking place in vivo.
The elucidation of local demethylation mechanisms appears
essential to establish whether DNA methylation plays a role
during vertebrate development. We focus this review on the
various mechanisms that could be involved in this elusive pro-
cess and analyse two aspects: biochemical mechanism and
targeting. We will discuss the various observations made
throughout the last 10 years in light of the results we have
obtained during the study of the regulation of a model tissue-
speci¢c gene.
1.2. Regulation of local DNA demethylation by the
glucocorticoid receptor (GR)
We are studying the mechanisms of transcriptional activa-
tion by nuclear receptors and we focus our studies on the
glucocorticoid regulation of the model tyrosine aminotransfer-
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ase (Tat) gene. This gene is expressed speci¢cally in liver cells,
is turned on at birth and its transcription is activated by
glucocorticoids in the adult. A key element in glucocorticoid
response and developmental induction is an enhancer located
at 32.5 kb consisting of multiple binding sites for the GR and
accessory transcription factors [20]. Using genomic footprint-
ing and chromatin immunoprecipitation, we determined the
actual events occurring in cultured hepatoma cells and we
could show that the GR uses a multistep mechanism to recruit
successively the accessory DNA binding proteins that assist in
the activation process [21]. Chromatin is ¢rst remodelled over
a 350 bp region within 15 min of GR activation, allowing
recruitment of transcription factor HNF-3 [22]. These events
are reversible following hormone withdrawal. Prolonged glu-
cocorticoid treatment elicits progressive demethylation of all
four MeCpGs located within the remodelled area; demethyla-
tion is complete within 3 days [23]. Nearby CpGs located
outside the remodelled area remain methylated. Following
demethylation, two additional transcription factors are re-
cruited at sites overlapping the CpGs. In contrast to chroma-
tin remodelling and transcription factor recruitment, demethy-
lation is stable and persists for months following hormone
withdrawal. As responses to subsequent glucocorticoid stim-
ulation are stronger and faster, demethylation appears to pro-
vide memory of the ¢rst stimulation. During development,
this demethylation occurs before birth, at a stage where the
Tat gene is not yet inducible [23]. It might thus prepare the
enhancer to allow the neonatal Tat gene induction that occurs
in response to enhancer activation by hypoglycemia [20].
Glucocorticoid-dependent demethylation of the 32.5 Tat
enhancer in cultured hepatoma cells is a well-de¢ned system
suitable for the study of a demethylation mechanism taking




MeCpG dinucleotides display a symmetrical con¢guration
that allows conservation of the methylation pattern following
replication. The replication machinery incorporates unmeth-
ylated cytosine in the newly synthesised strand. The resulting
hemimethylated sites are converted back to fully methylated
sites by the maintenance methyltransferase DNMT1 that acts
preferentially on hemimethylated CpGs (Fig. 1A). DNMT1
acts soon after replication because the enzyme is targeted to
replication foci through its interaction with the DNA poly-
merase clamp PCNA [24]. Demethylation of MeCpG could
simply result from an absence of maintenance methylation
after replication. This kind of mechanism would be a passive
one since it does not involve any demethylating enzyme.
This passive process must take place during several DNA
replication cycles to ensure that a signi¢cant part of the
daughter molecules are e¡ectively demethylated: three rounds
of replication demethylate only 87.5% of the CpG. This ¢gure
is consistent with the kinetics of demethylation of the mater-
nal genome that is observed during early mouse development
[25], and that we observe for the local glucocorticoid-regu-
lated demethylation of the 32.5 Tat enhancer [23]. Replica-
tion-dependent and therefore presumably passive demethyla-
tion of transfected DNA molecules has been observed in
several instances [26,27].
2.2. Active demethylation
An active demethylation mechanism, i.e. demethylation in
the absence of replication, has also been described. In mice,
global demethylation of the zygotic paternal genome after
fertilisation appears to occur by an active mechanism [28].
Local demethylation of transfected DNA molecules that do
not replicate has also been observed [18,29]. Both active de-
methylation of fully methylated CpGs to produce hemimeth-
ylated molecules, and demethylation of hemimethylated sites
have been observed with transfected DNA molecules [27,29].
Even though it is clear that active demethylation occurs in
some instances, the nature of the enzyme(s) responsible for
this modi¢cation has not been unequivocally established to
date. Three main biochemical mechanisms have been pro-
posed but none has yet either been proven to operate under
relevant physiological conditions or gained wide acceptance.
They di¡er in the ¢rst step performed by the putative enzyme
named demethylase: direct replacement of the methyl moiety
by a hydrogen atom, excision of the methylated base, or ex-
cision of the methylated nucleotide, possibly with a few sur-
rounding nucleotides (Fig. 2). The second and third mecha-
nisms imply further steps to repair the DNA lesion initiated
by the demethylases, either base or nucleotide excision repair
[30].
An enzymatic activity that is believed to demethylate with-
out altering the phosphodiester backbone was isolated from
human cells [31,32]. The demethylase was suggested to be
Fig. 1. Mechanisms of maintenance and modi¢cation of methylation
patterns. (A) Maintenance of the methylation patterns by DNMT1
following DNA replication. (B) Possible demethylation events initi-
ated by a passive step. (C) Possible demethylation events initiated
by an active step.
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MBD2b, which appeared to demethylate DNA in vitro, but
this claim is contested and could not be independently repro-
duced [33,34]. In addition, the amazing biochemistry of the
reaction and the puri¢cation steps have raised widespread
concerns [5,35]. Indeed, the biochemical properties of the pu-
tative demethylase activity varied widely during puri¢cation
through successive ion exchange columns and the enrichment
factors were surprisingly high even when the activity was
eluted in the non-resolved fractions (see discussions in
[5,35]). Furthermore, the proposed demethylation mechanism
is in con£ict with generally admitted thermodynamic and
chemical reaction theories as previously discussed [5]. The
inactivation of the MBD2 gene should allow to establish
whether this activity is involved in DNA demethylation in
vivo.
The mechanism involving base excision is more docu-
mented. Using chicken embryo nuclear extracts that can pro-
mote active demethylation, a demethylase has been puri¢ed by
Jost and colleagues [36,37]. The enzyme, a MeC-DNA-glyco-
sylase, acts preferentially on hemimethylated CpGs and ini-
tiates demethylation by breaking the glycosidic bond of MeC,
thus leaving an abasic site that should be further processed by
an AP-endonuclease and other DNA repair enzymes [30].
Throughout puri¢cation, the enzyme copuri¢ed with the
DNA repair enzyme G/T mismatch DNA-glycosylase
(TDG) and it turned out in the end that TDG was able to
carry out the MeC-DNA-glycosylase reaction [36,37]. It is not
fully clear whether TDG is the initially described activity.
Furthermore, several aspects of the enzymatic assays used
are worrying. Neither recombinant TDG, nor the puri¢ed
chicken demethylation complex showed e⁄cient MeC-DNA-
glycosylase activity as they converted only a minor proportion
of the substrate in 1 h reactions that contained a 10-fold
molar excess of enzyme over substrate [36,37]. In addition,
RNA was found to be essential for MeC-DNA-glycosylase
activity of the puri¢ed chick embryo enzyme, whereas re-
combinant TDG was active in the absence of RNA [37^39].
The putative RNA requirement has been inferred following
RNase treatment of the puri¢ed chicken enzyme. Reactions
were carried out using similar amounts of glycosylase and
RNase, both enzymes being in 100-fold excess over substrate
DNA. At these excesses, RNase has been shown to coat the
substrate DNA protecting it unspeci¢cally from the demeth-
ylase [40]. Addition of RNA at a 1000-fold molar excess over
substrate relieved the inhibitory e¡ect of RNase, and some
RNA sequence speci¢city of this e¡ect was observed [37^39].
Another G/T mismatch glycosylase, MBD4, which preferen-
tially acts on G/T mismatch resulting from MeC deamination
within the MeCpG dinucleotide [41], has also been shown by
Jost and colleagues to possess a weak MeC-glycosylase activity
on hemimethylated substrates [42]. In contrast, Bird, Jiricny
and colleagues found that MBD4 had no MeC-DNA-glycosy-
lase activity [41]. It is not clear whether these discrepancies are
due to di¡erences in the excess of enzymes to substrate used,
to deamination of some of the MeC within the substrate creat-
ing unappreciated G/T mismatches, or to other variations in
the experimental conditions. It would be important to show,
in particular through genetic experiments, whether these gly-
cosylases operate in vivo to demethylate MeCpG.
Another glycosylase acting on MeC within fully methylated
CpGs has been observed in vitro [43], but the validity of this
result has been questioned [44]. The original authors have
later reiterated their claim using partially puri¢ed enzyme
preparation [45]. More extensive characterisation is necessary
to ascertain the existence of this activity.
Finally, demethylation through excision of the dinucleotide
MeCpG appears to occur in vitro [46]. This activity was ob-
served upon analysis of the conversion from fully methylated
to hemimethylated substrate in extracts of cells able to pro-
mote such conversion of transfected DNA. It was ¢rst
thought that RNA has an active role in the demethylation
reaction as an acceptor of the dinucleotide but this was later
reevaluated following demonstration of the aforementioned
protective coating of the substrate by RNases [40]. Despite
this reevaluation, the demethylase activity per se has been
observed independently in this critical study. This demethylase
has not yet de¢nitively been characterised.
In conclusion, the presently available data are far from
clear, the biochemical approaches have been rather frustrating
and the demethylation mechanism remains to be ¢rmly estab-
lished. In favour of an active demethylation mechanism caus-
ing DNA strand breaks during the process, we have observed
such breaks during the glucocorticoid-induced demethylation
of the Tat enhancer (unpublished results).
2.3. Respective advantages of the di¡erent mechanisms
Two steps are necessary to demethylate a MeCpG on both
strands, and any combination of active or passive mechanisms
could theoretically occur (Fig. 1B,C). However, the relative
e⁄ciencies of these combinations di¡er. An exclusively passive
mechanism is ine⁄cient, as it requires several rounds of DNA
replication to achieve signi¢cant demodi¢cation (Fig. 1B).
Such a mechanism appears poorly adapted if DNA methyla-
tion participates e¡ectively in the control of gene expression
during development, as it would not allow rapid reprogram-
ming of gene expression following a single DNA replication
event. In contrast, an entirely active mechanism could permit
a rapid demethylation of both strands (Fig. 1C). However, as
the best established active demethylation mechanisms avail-
able to date provoke nicks or gaps in DNA, double-stranded
breaks could occur if one MeCpG, or two or more nearby
MeCpGs are simultaneously processed on the two DNA
strands. To avoid such deleterious events, demethylation
should only occur on one strand at a time. With an active^
Fig. 2. Possible levels of action of the demethylases.
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active process, this could be ensured in either of two ways: (a)
the demethylase machinery occupies the site as long as it is
not fully repaired and prevents cleavages at nearby MeCpGs;
(b) the demethylase machineries are not abundant and are not
recruited e⁄ciently, thus lowering to a negligible level the
probability of simultaneous processing of nearby sites. In ad-
dition, if di¡erent demethylases process the fully methylated
and the hemimethylated sites, they could act asynchronously.
As discussed previously, such demethylases have been ob-
served in vitro.
A passive^active mechanism would e⁄ciently demethylate
both strands of MeCpGs in a single replication event while
preventing double-stranded break formation (Fig. 1B). In-
deed, all MeCpGs that would be actively demethylated after
replication are on the same DNA strand. The existence of
such a mechanism is supported by the identi¢cation of a
MeC-glycosylase which catalyses demethylation preferentially
on hemimethylated molecules [17,36], and by a two-step de-
methylation event involving a single replication event [27].
Finally, an active^passive mechanism could also occur be-
cause, as previously described, there appears to be a demeth-
ylase converting fully methylated CpGs to a hemimethylated
site [29,46]. However, such a mechanism is not much more
e⁄cient than a fully passive one, as only one of the two
daughter molecules is demethylated on both strands after a
single replication event (Fig. 1C).
3. Targeting
DNA demethylation of regulatory elements of housekeep-
ing and tissue-speci¢c genes is often restricted to regions
where transcription factors bind and where chromatin is hy-
persensitive to DNase I cleavage. It is likely that these events
target the demethylation process. Methylation can sometimes
spread over several kilobases beyond the regulatory regions as
observed for the immunoglobulin genes. In this case, the en-
hancer is su⁄cient for enhancer-proximal demodi¢cation, but
particular regulatory sequences, with ‘matrix attachment’
properties, are required to allow demethylation of enhancer-
distal sites [47,48]. In the absence of precise knowledge of the
demethylation machinery, the mechanisms allowing targeting
of demethylation to speci¢c sites are far from clear, but we
will attempt to review the various possibilities.
3.1. Targeting of the passive mechanism (Fig. 3A)
If demethylation results from the inhibition of maintenance
methylation, how could such a transient inhibition be exerted
locally? One model, based on the observation that virus-de-
rived episomal vectors are demethylated at sites where tran-
scription factors bind with high a⁄nity, relies on steric hin-
drance: transcription factors protect their cognate site from
DNMT1 action (Fig. 3A) [27,49]. The model requires the
protein to reoccupy its site quickly after being displaced by
the replication fork as DNMT1 follows it through its inter-
action with PCNA. This presumably necessitates a relatively
high concentration of high a⁄nity transcription factors. Such
a model does not account for the demethylation that occurs at
sites that are distinct, and eventually remote, from the sites
triggering the demethylation [29,47,48]. In addition, it could
not account for the glucocorticoid-regulated demethylation of
the Tat enhancer, because we have observed, using genomic
footprinting, that occupancy of the CpG-containing transcrip-
tion factor binding sites rather follows than precedes their
demethylation [23]. The recruitment of an active demethyla-
tion mechanism recognising hemimethylated sites could also
be responsible for the exclusion of DNMT1, as suggested
previously [17]. However, in such a case, the half-life of the
hemimethylated intermediates should be very short, in con-
trast to what has been observed with replicating episomal
vectors [27].
Replication-dependent demethylation of speci¢c sites in
Xenopus embryo is strongly stimulated by the trans-activation
domain of the triggering transcription factor [26]. Activation
domains could simply facilitate transcription factor interac-
tion with DNA or act directly, for example through modi¢-
cations of some components of the replication machinery to
prevent methylation. The most direct way could be through
Fig. 3. Possible levels of targeting of demethylation. (A) Targeting
of passive demethylation. (B) Targeting of active demethylation.
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altered recruitment of DNMT1 to the replication fork. For
example, it has been shown that p21WAF1 can compete with
DNMT1 for interaction with PCNA [50]. Such a mechanism
appears better adapted for a large-scale than for a local de-
methylation, the latter requiring very dynamic interactions
between PCNA, DNMT1 and inhibitors. Foci of ‘replication
factories’ are rather static, but it is still possible that the in-
teractions of proteins with PCNA within the factories are
dynamic enough to allow for such a local demethylation
[24]. Alternatively, DNMT1 associated to the replication ma-
chinery could be transiently inactivated through either cova-
lent modi¢cations or recruitment of an inhibitor. A number of
the coactivators recruited by transcription factors that are
able to trigger DNA demethylation, like GR, can phosphor-
ylate, acetylate, or methylate other proteins [51]. Yet, it has
not been shown whether such modi¢cations of DNMT1 could
inactivate it. Small molecular weight inhibitors of DNMT
have been found in tissues [52], but it is not known if such
compounds could be transiently targeted by regulatory fac-
tors.
An alternative possibility is that the replication machinery
could be able to monitor chromatin structure and to de-
methylate in response to the detection of an active chromatin
state. Indeed, evidences are accumulating suggesting that the
replication machinery contributes to epigenetic inheritance
and to the restoration of the chromatin state as it existed prior
to replication [53]. This implies that the replication machinery
has a chromatin-monitoring ability. Demethylated CpGs are
most often found at sites where chromatin remodelling creates
DNase I hypersensitivity. As mentioned previously, GR trig-
gers chromatin remodelling of the Tat enhancer followed by
demethylation of all CpGs within the 350 bp long remodelled
area [21,23]. Histone acetylation is unlikely to be responsible
for this demethylation for two reasons. First, treatment of
cells with trichostatin A, a drug inducing histone hyperacety-
lation, does not trigger demethylation [23]. Second, chromatin
immunoprecipitation analysis reveals that GR-induced his-
tone acetylation spreads beyond the area where demethylation
occurs ([21]; M. Flavin and T.G., unpublished results). How-
ever, there is a perfect overlap between the areas where CpGs
are demethylated and where chromatin is remodelled by ac-
tivities presumed to be members of the Swi/Snf family of
ATPases.
Another type of reprogramming of the replication machi-
nery has been proposed to allow DNA demethylation [54].
This model, based on the observation that CpG islands are
often associated with replication origins, suggests that there is
a particular replication machinery initiating replication that
di¡ers from the elongating machinery by its inability to main-
tain methylation. Transcription factors would trigger demeth-
ylation by inducing a DNA replication initiation event in
the vicinity of their binding sites. This is an attractive model
but it necessitates the existence of di¡erent classes of replica-
tion origins with di¡erent abilities to methylate DNA. Indeed,
whereas some replication origins are located within methyla-
tion-free CpG islands, others are enriched in MeCpGs and
even appear to require CpG methylation to function [55,56].
Finally, instead of locally and transiently modifying the
replication machinery, the locus to be demethylated could
also be relocated in a nuclear area devoid of maintenance
activity upon a speci¢c signal. This is not an attractive possi-
bility for most local demethylation events, as it implies very
rapid and transient relocation. However, such a mechanism
could operate when local demethylation spreads over several
kilobases [47,48].
3.2. Targeting of the active mechanism (Fig. 3B)
The targeting of active demethylation amounts to locally
recruiting the demethylase. Such recruitment could be direct,
some transcription factors interacting with DNA demethylase
complexes, or indirect, through chromatin remodelling that
could allow demethylase interaction the way it allows tran-
scription factor recruitment (e.g. [22]). A passive^active mech-
anism would not necessarily need the targeting of a demethy-
lase. Indeed, the demethylation of hemimethylated sites
created by a passive step could be completed by a demethylase
that would demethylate any hemimethylated substrate met in
the genome. However, if the demethylase follows the replica-
tion machinery, as does the maintenance methyltransferase,
transcription factors or chromatin remodelling could instruct
the replication machinery to either remethylate or fully deme-
thylate CpGs. Such a replication machinery with multiple
DNA modi¢cation potentials would ensure integration of rap-
id and precise demethylation in a single replication event.
4. Conclusions
Numerous DNA demethylation mechanisms have been ob-
served in vitro and in transfection assays but only a subset of
the responsible enzymes have been identi¢ed and it is not clear
whether they are involved in demethylation in vivo. The prop-
erties of the demethylation processes observed di¡er widely
and it is likely that there is more than one mechanism. This
diversity may allow ¢ne-tuning of demethylation by di¡erent
classes of regulatory factors. The mechanisms allowing target-
ing of the demethylation to speci¢c sequences are far from
clear. It is urgent to de¢ne which mechanisms are really at
work in living cells and to identify the responsible enzymes, as
this should allow to de¢nitively establish whether the control
of DNA methylation patterns is important for vertebrate de-
velopment. In addition, as deregulation of the control of
methylation patterns appears to participate to tumourigenesis,
this could lead to the identi¢cation of novel tumour-promot-
ing or -suppressing genes.
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